REG - Tristel PLC - Issue of Equity

TristelAnnouncement

10/08/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210810:nRSJ0744Ia&default-theme=true

RNS Number : 0744I  Tristel PLC  10 August 2021

 

Tristel plc

("Tristel" or the "Company")

Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention,
contamination control and hygiene products, announces that, following an
exercise of options, it has issued and allotted 28,800 new ordinary shares in
the Company ("Ordinary Shares"). Application will be made for the new Ordinary
Shares to be admitted to trading on AIM and dealings are expected to commence
on or around the 16 August 2021.

The new Ordinary Shares will rank pari passu with the existing shares of the
Company. Following the exercise of options, the Company's issued share capital
consists of 47,172,243 Ordinary Shares. Accordingly, the figure of 47,172,243
may be used by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in the Company under the FCA's Disclosure Guidance
and Transparency Rules.

For further information please contact:

 

 Tristel plc                                     Tel: 01638 721 500
 Paul Swinney, Chief Executive Officer
 Liz Dixon, Finance Director

 Walbrook PR Ltd                                 Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus                                    Mob: 07980 541 893
 Lianne Cawthorne                                Mob: 07854 391 303

 finnCap                                         Tel: 020 7220 0500
 Geoff Nash / Charlie Beeson, Corporate Finance
 Alice Lane, ECM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBIGDIRDGDGBC